Mesacol CR 500mg Tablet contains Mesalazine 500mg, an anti-inflammatory agent primarily used in the treatment of inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. Mesalazine acts locally on the colonic mucosa to reduce inflammation by inhibiting the production of pro-inflammatory mediators like prostaglandins and leukotrienes. The controlled-release formulation ensures gradual release of the active ingredient throughout the gastrointestinal tract, enhancing therapeutic efficacy while minimizing systemic absorption and associated side effects. Mesacol CR is indicated for the induction and maintenance of remission in patients with mild to moderate ulcerative colitis and for the management of colonic inflammation in Crohn’s disease. The recommended dosage varies depending on the severity of the condition and patient response, and should be determined by a healthcare professional. Common adverse effects may include headache, nausea, abdominal pain, and diarrhea, though these are generally mild and transient. Patients with hypersensitivity to salicylates or related compounds should avoid this medication. Regular monitoring of renal function is advised during prolonged therapy. Mesacol CR 500mg Tablet should be used under medical supervision, with adherence to prescribed dosage to optimize clinical outcomes and minimize potential risks.